Clinical Trial Update: An Observational Study to Assess Change in Disease Activity and Adverse Events of Adalimumab in Chinese Pediatric Participants With Polyarticular Juvenile Idiopathic Arthritis (pJIA)

View source ↗

Summary

This completed observational study evaluated changes in disease activity and adverse events in Chinese pediatric participants with polyarticular juvenile idiopa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polyarticular Juvenile Idiopathic Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: AbbVie | Conditions: Polyarticular Juvenile Idiopathic Arthritis | Status: COMPLETED